Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2009-11-20 (16 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: TOULON (83000), Var
PHARMACIE DE L'AGUILLON : revenue, balance sheet and financial ratios
PHARMACIE DE L'AGUILLON is a French company
founded 16 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in TOULON (83000),
this company of category PME
shows in 2020 a revenue of 2.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE L'AGUILLON (SIREN 518289061)
Indicator
2024
2023
2020
2019
2016
Revenue
N/C
N/C
2 333 971 €
2 080 966 €
2 045 157 €
Net income
203 399 €
211 965 €
152 990 €
126 821 €
148 533 €
EBITDA
N/C
N/C
234 648 €
120 705 €
192 132 €
Net margin
N/C
N/C
6.6%
6.1%
7.3%
Revenue and income statement
In 2024, PHARMACIE DE L'AGUILLON generates positive net income of 203 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 149 k€ -> 203 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
203 399 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 11%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 81%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
10.577%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
81.331%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE L'AGUILLON
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2019
2020
2023
2024
Debt ratio
105.744
58.93
105.777
12.19
10.577
Financial autonomy
39.69
57.48
42.602
79.811
81.331
Repayment capacity
6.27
7.334
6.636
None
None
Cash flow / Revenue
7.647%
5.191%
7.04%
None%
None%
Sector positioning
Debt ratio
10.582024
2020
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent-27 pts over 3 years
In 2024, the debt ratio of PHARMACIE DE L'AGUILLON (10.58) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
81.33%2024
2020
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent+32 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DE L'AGUILLON (81.3%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
6.64 years2020
2020
Q1: 1.45 years
Med: 4.71 years
Q3: 9.3 years
Average
In 2020, the repayment capacity of PHARMACIE DE L'AGUILLON (6.64) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 160.46. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
160.464
Liquidity indicators evolution PHARMACIE DE L'AGUILLON
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2019
2020
2023
2024
Liquidity ratio
70.045
155.31
135.375
153.415
160.464
Interest coverage
5.719
6.977
18.16
None
None
Sector positioning
Liquidity ratio
160.462024
2020
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average+14 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DE L'AGUILLON (160.46) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
18.16x2020
2020
Q1: 0.68x
Med: 3.87x
Q3: 8.37x
Excellent
In 2020, the interest coverage of PHARMACIE DE L'AGUILLON (18.2x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE L'AGUILLON
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2019
2020
2023
2024
Operating WCR
-27 937 €
265 240 €
224 248 €
0 €
0 €
Inventory turnover (days)
31
34
30
0
0
Customer payment term (days)
6
13
14
1682
0
Supplier payment term (days)
40
38
44
956
0
Positioning of PHARMACIE DE L'AGUILLON in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DE L'AGUILLON is estimated at
2 839 600 €
(range 1 977 452€ - 4 248 204€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1977k€2839k€4248k€
2 839 600 €Range: 1 977 452€ - 4 248 204€
NAF 5 année 2024
Valuation method used
Net Income Multiple
203 399 €
×
14.0x
=2 839 600 €
Range: 1 977 453€ - 4 248 205€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE L'AGUILLON with other companies in the same sector:
Frequently asked questions about PHARMACIE DE L'AGUILLON
What is the revenue of PHARMACIE DE L'AGUILLON ?
The revenue of PHARMACIE DE L'AGUILLON in 2020 is 2.3 M€.
Is PHARMACIE DE L'AGUILLON profitable?
Yes, PHARMACIE DE L'AGUILLON generated a net profit of 203 k€ in 2024.
Where is the headquarters of PHARMACIE DE L'AGUILLON ?
The headquarters of PHARMACIE DE L'AGUILLON is located in TOULON (83000), in the department Var.
Where to find the tax return of PHARMACIE DE L'AGUILLON ?
The tax return of PHARMACIE DE L'AGUILLON is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE L'AGUILLON operate?
PHARMACIE DE L'AGUILLON operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart